We are a clinical stage biopharmaceutical company with extensive drug development experience in areas of new chemical entities and novel drug delivery systems. Our drug delivery platform technologies are clinically validated with products approved in several markets.
At SPARC we believe that investment in good science and the rigorous pursuit of R&D excellence can translate into new medicines that can provide benefits to the patients and community at large.
We are committed to alliances, partnerships, and collaborations and will opportunistically evaluate assets that have the potential to expand our pipeline, geographic reach, or technological base.
Our therapeutic areas of interest are Oncology, Neuro-degenerative diseases, Ophthalmology, Dermatology and Pain.